BACKGROUND: Tango dancing has been effective in improving measures of physical function in people with Parkinson disease (PD). However, all previous studies were institution-based, tested participants on medication, and employed short-term interventions. OBJECTIVE: To determine the effects of a 12-month community-based tango program for individuals with PD on disease severity and physical function. METHODS:Sixty-two participants were randomly assigned to a twice weekly, community-based Argentine Tango program or a Control group (no intervention). Participants were assessed off anti-Parkinson medication at baseline, 3, 6, and 12 months. The primary outcome measure was the Movement Disorders Society-Unified Parkinson Disease Rating Scale 3 (MDS-UPDRS-3). Secondary outcome measures were the MDS-UPDRS-1, MDS-UPDRS-2, MiniBESTest balance test; Freezing of Gait Questionnaire (FOG_Q); 6-Minute Walk Test (6MWT); gait velocity for comfortable forward, fast as possible forward, dual task, and backward walking; and Nine-Hole Peg Test (9HPT). RESULTS: Groups were not different at baseline. Overall, the Tango group improved whereas the Control group showed little change on most measures. For the MDS-UPDRS-3, there was no significant change in the Control group from baseline to 12 months, whereas the Tango group had a reduction of 28.7% (12.8 points). There were significant group by time interactions for MDS-UPDRS-3, MiniBESTest, FOG_Q, 6MWT, forward and dualtask walking velocities, and 9HPT in favor of the dance group. CONCLUSIONS: Improvements in the Tango group were apparent off medication, suggesting that long-term participation in tango may modify progression of disability in PD.
RCT Entities:
BACKGROUND: Tango dancing has been effective in improving measures of physical function in people with Parkinson disease (PD). However, all previous studies were institution-based, tested participants on medication, and employed short-term interventions. OBJECTIVE: To determine the effects of a 12-month community-based tango program for individuals with PD on disease severity and physical function. METHODS: Sixty-two participants were randomly assigned to a twice weekly, community-based Argentine Tango program or a Control group (no intervention). Participants were assessed off anti-Parkinson medication at baseline, 3, 6, and 12 months. The primary outcome measure was the Movement Disorders Society-Unified Parkinson Disease Rating Scale 3 (MDS-UPDRS-3). Secondary outcome measures were the MDS-UPDRS-1, MDS-UPDRS-2, MiniBESTest balance test; Freezing of Gait Questionnaire (FOG_Q); 6-Minute Walk Test (6MWT); gait velocity for comfortable forward, fast as possible forward, dual task, and backward walking; and Nine-Hole Peg Test (9HPT). RESULTS: Groups were not different at baseline. Overall, the Tango group improved whereas the Control group showed little change on most measures. For the MDS-UPDRS-3, there was no significant change in the Control group from baseline to 12 months, whereas the Tango group had a reduction of 28.7% (12.8 points). There were significant group by time interactions for MDS-UPDRS-3, MiniBESTest, FOG_Q, 6MWT, forward and dual task walking velocities, and 9HPT in favor of the dance group. CONCLUSIONS: Improvements in the Tango group were apparent off medication, suggesting that long-term participation in tango may modify progression of disability in PD.
Authors: Falisha J Karpati; Chiara Giacosa; Nicholas E V Foster; Virginia B Penhune; Krista L Hyde Journal: Exp Brain Res Date: 2015-12-15 Impact factor: 1.972
Authors: Giselle M Petzinger; Beth E Fisher; Sarah McEwen; Jeff A Beeler; John P Walsh; Michael W Jakowec Journal: Lancet Neurol Date: 2013-07 Impact factor: 44.182
Authors: Kerri S Rawson; Marie E McNeely; Ryan P Duncan; Kristen A Pickett; Joel S Perlmutter; Gammon M Earhart Journal: J Neurol Phys Ther Date: 2019-01 Impact factor: 3.649
Authors: Laurie A King; Martina Mancini; Katrijn Smulders; Graham Harker; Jodi A Lapidus; Katrina Ramsey; Patricia Carlson-Kuhta; Brett W Fling; John G Nutt; Daniel S Peterson; Fay B Horak Journal: Neurorehabil Neural Repair Date: 2020-04-04 Impact factor: 3.919
Authors: Janey Prodoehl; Miriam R Rafferty; Fabian J David; Cynthia Poon; David E Vaillancourt; Cynthia L Comella; Sue E Leurgans; Wendy M Kohrt; Daniel M Corcos; Julie A Robichaud Journal: Neurorehabil Neural Repair Date: 2014-06-24 Impact factor: 3.919